Zusammensetzung information

Zusammensetzung, Synonyme

• Trastuzumab emtansine
• Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 γ1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer, tetraamide with N² -[3-[[1-[(4-carboxycyclohexyl)methyl]-2,5-dioxo-3- pyrrolidinyl]thio]-1-oxopropyl]-N² -deacetylmaytansine
• Immunoglobulin G1, anti-(human receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1, p185erbB2, MLN 19 or CD340)); humanized mouse monoclonal rhuMab HER2 γ1 heavy chain (223-214 )-disulfide with humanized mouse monoclonal rhuMab HER2 rhuMab HER2 rhuMab HER2 κ light chain, dimer (229-229 :232-232 )- bisdisulfide in which the 6-amino groups of an average of 3.5 lysine residues are amidified by 4-({3-[(3-{[(1S)-2-{[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21- hydroxy-12,20-dimethoxy-2,5,9,16-te
• PRO132365 (Genentech, USA)
• T-DM1 (Genentech, USA)
• Trastuzumab-MCC-DM1 (Genentech, USA)
• Trastuzumabum emtansinum
• Trastuzumab emtansina
• Immunoglobulin G1-kappa, anti-[Homo sapiens ERBB2 (epidermal growth factor receptor 2, HER-2, p185c-erbB2, NEU, EGFR2)], humanized monoclonal antibody conjugated to maytansinoid DM1; gamma1 heavy chain (1-449) [humanized VH (Homo sapiens IGHV3-66*01 (81.60%)-(IGHD)-IGHJ6*01 T123>L) [8.8.13] (1-120)-Homo sapiens IGHG1*03 (121-449) CH1 R120>K], (223-214 )-disulfide with kappa light chain (1 -214 ) [humanized V-KAPPA (Homo sapiens IGKV1-39*01 (86.30%)-IGKJ1*01) [6.3.9] (1 -107 )-Homo sapiens IGKC*0
• Ado-Trastuzumab emtansin
• Ado trastuzumab emtansine
• Trastuzumab emtansin

Andere Arzneimittel